Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Baxter
Johnson and Johnson
Colorcon
Harvard Business School

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Quinapril hydrochloride - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for quinapril hydrochloride and what is the scope of freedom to operate?

Quinapril hydrochloride is the generic ingredient in two branded drugs marketed by Pfizer Pharms, Actavis Elizabeth, Actavis Labs Fl Inc, Ani Pharms Inc, Apotex Inc, Aurobindo Pharma Ltd, Invagen Pharms, Lupin, Mylan, Prinston Inc, Sun Pharm Inds Ltd, and Yaopharma Co Ltd, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for quinapril hydrochloride. Thirteen suppliers are listed for this compound. There is one tentative approval for this compound.

Recent Clinical Trials for quinapril hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of NebraskaPhase 4
PfizerN/A
St Thomas' Hospital, LondonPhase 3

See all quinapril hydrochloride clinical trials

Recent Litigation for quinapril hydrochloride

Identify potential future generic entrants

District Court Litigation
Case NameDate
Apotex, Inc. v. UCB, Inc.2012-04-20
Apotex, Inc. v. Mylan Pharmaceuticals, Inc.2012-04-20
Fleetwood Enterprises, Inc.2009-03-10

See all quinapril hydrochloride litigation

Generic filers with tentative approvals for QUINAPRIL HYDROCHLORIDE
Applicant Application No. Strength Dosage Form
  See Pricing  See PricingEQ 40MG BASETABLET;ORAL
  See Pricing  See PricingEQ 20MG BASETABLET;ORAL
  See Pricing  See PricingEQ 10MG BASETABLET;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for quinapril hydrochloride
Synonyms for quinapril hydrochloride
(3S-(2(R*(R*)),3R*))-2-(2-((1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)AMINO)-1-OXOPROPYL)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXYLIC ACID MONOHYDROCHLORIDE
(3S)-2-(N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid Hydrochloride
(3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
(3S)-2-[(2S)-2-{[(2S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YL]AMINO}PROPANOYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID HYDROCHLORIDE
(3S)-2-{(2S)-2-[(1S)-1-ethoxycarbonyl-3-phenylpropylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
(3S)-2-{N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
(S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
(S)-2-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-
(S)-2-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride
(S)-2-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, 1-ethyl ester, monohydrochloride
(S)-2-[(S)-N-[(S)-1-Carboxy-3-phenylpropyl]alanyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid 1-Ethyl Ester Hydrochloride
[3S-[2[R*(R*)], 3R*]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, monohydrochloride
2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid
2-ylamino)propanoyl)-1,2,3,4-
3-isoquinolineacrboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3S-(2(R*(R*)),3R*))-
3-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, monohydrochloride, (3S-(2(R*(R*)),3R*))-
3-Isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, monohydrochloride, (3S-(2(R*(R*)),3R*))
3-Isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, monohydrochloride, (3S-(2(R*(R*)),3R*))-
3-isoquinolinecarboxylicacid,1,2,3,4-tetrahydro-2-(2-((1-(ethoxycarbonyl)-3-p
33067B3N2M
586Q558
82586-55-8
AB07655
AB2000675
AC-1655
AC1L1HXI
Accupril
Accupril (TN)
Accuprin
Accupro
Accupron
Accuretic
Acequin
Acuitel
Acuprel
AKOS015888532
AN-14706
AS-14026
Asig
BC206223
C07340
C25H30N2O5.HCl
CAS-82586-55-8
CCG-39543
CHEBI:8714
CHEMBL1201011
CI 906
CI-906
CI-906 (CN-109452)
CI906
Conan
Continucor
CPD000499582
CS-2591
D00459
DSSTox_CID_1221
DSSTox_GSID_21221
DSSTox_RID_76019
DTXSID3021221
Ectren
Hemokvin
HMS1922C15
HSDB 7046
HY-B0477
IBBLRJGOOANPTQ-JKVLGAQCSA-N
Korec
Koretic
Lidaltrin
LS-85471
MCULE-2623123657
MFCD00889215
MLS001076683
MolPort-003-666-434
monohydrochloride,(3s-(2(r*(r*)),3r*))-henylpropyl)amino)-1-oxopropyl)
NC00722
NCGC00094997-01
NCGC00167962-06
NCGC00257944-01
NE45380
NSC-758222
NSC758222
PD 109452-2
PD-109,452-2
PD-109522
Pharmakon1600-01503076
Quinapril hydrochloride
Quinapril (hydrochloride)
Quinapril for peak identification, European Pharmacopoeia (EP) Reference Standard
Quinapril for system suitability, European Pharmacopoeia (EP) Reference Standard
QUINAPRIL HCL
Quinapril Hydrochloride ,(S)
Quinapril hydrochloride (Accupril)
Quinapril hydrochloride (JP17/USP)
Quinapril hydrochloride [USAN:USP]
Quinapril hydrochloride [USAN]
quinapril hydrochloride hydrochloride
Quinapril hydrochloride, >=98% (HPLC), solid
Quinapril hydrochloride, European Pharmacopoeia (EP) Reference Standard
Quinapril Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Quinapril hydrochloride, United States Pharmacopeia (USP) Reference Standard
Quinapril hydrochloride;
Quinapril N-Oxide
Quinapril.HCl
Quinazil
s2581
SAM002589972
SC-17215
SCHEMBL41404
SMR000499582
SPECTRUM1503076
SR-01000765404
SR-01000765404-2
SW199393-2
tetrahydroisoquinoline-3-carboxylic
Tox21_111381
Tox21_111381_1
Tox21_200390
UNII-33067B3N2M

US Patents and Regulatory Information for quinapril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 078457-003 Aug 24, 2007 AB RX No No   See Pricing   See Pricing   See Pricing
Pfizer Pharms ACCUPRIL quinapril hydrochloride TABLET;ORAL 019885-003 Nov 19, 1991 AB RX Yes No   See Pricing   See Pricing   See Pricing
Prinston Inc QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 205823-001 Sep 15, 2016 AB RX No No   See Pricing   See Pricing   See Pricing
Ani Pharms Inc QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 075504-002 Aug 24, 2007 AB RX No No   See Pricing   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for quinapril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms ACCUPRIL quinapril hydrochloride TABLET;ORAL 019885-002 Nov 19, 1991   See Pricing   See Pricing
Pfizer Pharms ACCUPRIL quinapril hydrochloride TABLET;ORAL 019885-004 Nov 19, 1991   See Pricing   See Pricing
Pfizer Pharms ACCUPRIL quinapril hydrochloride TABLET;ORAL 019885-004 Nov 19, 1991   See Pricing   See Pricing
Pfizer Pharms ACCUPRIL quinapril hydrochloride TABLET;ORAL 019885-001 Nov 19, 1991   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Medtronic
Merck
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.